An Open Clinical Trial to Assess Efficacy for Delaying Ossification and Improving Inflammation of Celebrex Plus/or Enbrel Treatment on Active Ankylosing Spondylitis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2016
At a glance
- Drugs Celecoxib (Primary) ; Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 13 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Feb 2017.
- 13 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Feb 2017.
- 13 Apr 2016 Status changed from recruiting to active, no longer recruiting.